GlassScriptPhysician profile
David C Vance
NPI 1043703176
$4,196.53
in general payments reported to CMS, 2019-2025
20 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,423 · 2020: $637 · 2021: $691 · 2022: $464 · 2023: $405 · 2024: $345 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $982.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,055.54 | 2019-2025 | Puraply, Apligraf, Cygnus Dual |
| Horizon Therapeutics Plc | $486.34 | 2019-2023 | Krystexxa |
| Wright Medical Technology, INC. | $375.29 | 2019-2020 | |
| Smith+Nephew, INC. | $346.19 | 2021-2025 | Pico, Grafix Pl |
| Depuy Synthes Sales INC. | $337.33 | 2019-2025 | Na |
| Osteomed LLC | $307.12 | 2020-2021 | |
| Paragon 28, INC. | $262.83 | 2019-2023 | Mtp |
| Integra Lifesciences Corporation | $197.57 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $194.31 | 2019-2020 | |
| Cardiovascular Systems INC. | $170.80 | 2019-2021 | |
| Bioventus LLC | $109.23 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $102.41 | 2019 | |
| Kci USA, INC. | $68.93 | 2019 | |
| In2bones USA, LLC | $42.18 | 2021 | |
| Nevro Corp. | $32.27 | 2024 | Senza |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $28.49 | 2022 | |
| Amgen INC. | $28.02 | 2024 | Krystexxa |
| Mimedx Group, INC. | $22.80 | 2025 | |
| Ossdsign USA Incorporated | $20.02 | 2025 | Ossdsign Catalyst |
| Kerecis Limited | $8.86 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Vance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.